<DOC>
	<DOCNO>NCT02665117</DOCNO>
	<brief_summary>Chlorthalidone ( CTD ) may produce various metabolic disturbance , include hypokalemia , activation Renin-Angiotensin- Aldosterone ( RAA ) system , oxidative stress , dyslipidemia , Fibroblast growth factor 23 ( FGF23 ) synthesis , magnesium depletion . These factor may interact contribute development insulin resistance metabolic syndrome . Smaller study suggest Potassium magnesium Citrate ( KMgCit ) ameliorate CTD- induced metabolic side effect independent correction hypokalemia . This study test KMgCit ameliorate CTD induce metabolic effect independent correction hypokalemia .</brief_summary>
	<brief_title>Preventing Metabolic Side Effects Thiazide Diuretics With KMgCitrate</brief_title>
	<detailed_description>CTD- induce metabolic side effect though dependent hypokalemia , subsequent study suggest CTD - induced side effect independent hypokalemia . On hand , magnesium depletion link increase Renin-Angiotensin- Aldosterone ( RAA ) system , development metabolic syndrome insulin resistance magnesium supplementation ameliorate effect . Participants participate double-blinded , parallel design study . After baseline evaluation participant take Chlorthalidone ( CTD ) alone 2-3 week . They randomize two equal group take KMgCit powder Potassium Chloride ( KCl ) powder along CTD 4 month . We speculate Mg depletion responsible hepatic fat deposition , produce insulin resistance . Co-administration KMgCit powder would avert magnesium ( Mg ) depletion , block hepatic fat deposition restore normal Mg status direct intestinal binding fat , thereby ameliorate insulin resistance . To test hypothesis , shall quantitate muscle Mg status hepatic fat content magnetic resonance spectroscopy ( MRS ) KMgCit . Change fast glucose , insulin resistance , serum potassium , FGF23 , aldosterone compare KCL KMgCit group 4 month .</detailed_description>
	<mesh_term>Sodium Chloride Symporter Inhibitors</mesh_term>
	<mesh_term>Chlorthalidone</mesh_term>
	<mesh_term>Diuretics</mesh_term>
	<mesh_term>Magnesium citrate</mesh_term>
	<criteria>â€¢ Treated untreated stage I hypertension Diabetes mellitus , Renal impairment ( serum creatinine &gt; 1.4 mg/dL ) , Any heart diseases congestive heart failure , sustain arrhythmia , coronary heart disease , Chronic regular NSAID use , Allergy thiazide diuretic , Gastroesophageal reflux disease ( GERD ) require treatment acid reduce agent antacid week , Esophagealgastric ulcer history gastrointestinal bleeding , Chronic diarrhea , vomit , Excessive sweating , Unprovoked hypokalemia ( serum K &lt; 3.5 mmol/L ) hyperkalemia ( serum K &gt; 5.3 mmol/L ) , Abnormal liver function test ( Aspartate transaminase ( AST ) Alanine transaminase ( ALT ) upper limit normal range ) , Subjects potassium supplement regular basis reason , patient primary aldosteronism , Pregnancy , History major depression , bipolar disorder , schizophrenia , History substance abuse , Gout , Metabolic alkalosis , serum bicarbonate &gt; 32 meq/L , Severe dietary salt restriction , less than1/2 spoonful 50 meq sodium/day . Claustrophobia Metal implant</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Hypokalemia</keyword>
	<keyword>Isoprostanes</keyword>
	<keyword>Insulin resistance</keyword>
	<keyword>Aldosterone</keyword>
	<keyword>Hepatic fat</keyword>
	<keyword>Muscle Magnesium</keyword>
	<keyword>Liver fat</keyword>
</DOC>